ASCO 2026 with Oncology Insider
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
ASCO 2026 with Oncology Insider
-
ナレーター：
-
著者：
In this episode of Meeting Mic, Mark Leiser, Healio's Oncology Insider, joins Shikha Jain, MD, to discuss top presentations, as well as pearls and perspectives from ASCO Annual Meeting.
· Daraxonrasib offers 'transformational' benefit in metastatic pancreatic cancer
· GLP-1s demonstrate 'large' & 'consistent' protective effects against cancer metastases
· Trial of early cancer detection test misses primary endpoint; secondary data 'promising'
· 'This matters': Hem/onc fellows embrace AI but lack formal training to guide its use
· Hem/onc 'bootcamp' significantly improves fellows' knowledge, clinical confidence
· Immunotherapy combination may improve outcomes in unresectable liver cancer
· Abemaciclib may be new standard for 'challenging' sarcoma subtype
For more of the latest breaking news in oncology, be sure to visit Oncology Insider.
We'd love to hear from you! For more from Dr. Jain, follow her on X: @ShikhaJainMD and on Instagram: @shikhajainmd. For more from Leiser, follow him on X: @_MarkLeiser or on LinkedIn.
Jain and Leiser report no relevant financial disclosures.